FENC
Fennec Pharmaceuticals Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website fennecpharma.com
- Employees(FY) 36
- ISIN CA31447P1009
Performance
-25.27%
1W
-31.38%
1M
-21.86%
3M
-12.87%
6M
-37.25%
YTD
-6.63%
1Y
Profile
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Technical Analysis of FENC 2024-05-10
Overview:
In analyzing the technical indicators for FENC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-14 20:44
- 2024-05-13 22:53
- 2024-05-13 19:20
- 2024-05-13 18:03
- 2024-05-07 06:15
- 2024-04-22 20:01
- 2024-04-05 07:00
- 2024-03-27 07:00
- 2024-03-25 13:00
- 2024-03-21 21:49
- 2024-03-21 17:04
Q4 2023 Fennec Pharmaceuticals Inc Earnings Call(Yahoo Finance)
- 2024-03-21 02:52
- 2024-03-20 18:00
- 2024-03-18 22:14
- 2024-03-18 18:01
- 2024-03-17 09:00
- 2024-02-28 18:04
- 2024-01-31 16:55
- 2024-01-05 14:01
- 2023-12-04 16:55
- 2023-11-09 03:50
- 2023-11-06 20:40
- 2023-11-06 13:10
Q3 2023 Fennec Pharmaceuticals Inc Earnings Call(Yahoo Finance)
- 2023-11-05 16:59
- 2023-10-29 18:45
- 2023-09-06 17:59
- 2023-08-10 00:53
- 2023-08-02 17:59
- 2023-07-30 17:30
- 2023-06-12 05:00
Fennec Announces Results of Annual Meeting(Yahoo Finance)
Page 1 of 4
previousnext